10x Genomics's total inventories for the quarter that ended in Mar. 2026 was MXN965 Mil. 10x Genomics's average total inventories from the quarter that ended in Dec. 2025 to the quarter that ended in Mar. 2026 was MXN989 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. 10x Genomics's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was MXN55.14.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
10x Genomics's Days Inventory for the
three
months ended in Mar. 2026 was 112.10.
Inventory Turnover measures how fast the company turns over its inventory within a year.
10x Genomics's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.81.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
10x Genomics's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.36.
10x Genomics (MEX:TXG) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
10x Genomics's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
10x Genomics's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
10x Genomics Total Inventories Related Terms
10x Genomics Total Inventories Historical Data
* Premium members only.
The historical data trend for 10x Genomics's Total Inventories can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
10x Genomics (MEX:TXG) has a Total Inventories of MXN965 Mil as of Mar. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for 10x Genomics and its competitors.
Is 10x Genomics' Total Inventories too high?
10x Genomics' current Total Inventories is MXN965 Mil. Overall, 10x Genomics has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does 10x Genomics' Total Inventories compare to WAY and DOCS?
10x Genomics' Total Inventories of MXN965 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Healthcare Providers & Services company?
A good Total Inventories depends on the Healthcare Providers & Services industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for 10x Genomics and its competitors. 10x Genomics's current Total Inventories is MXN965 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 10x Genomics stock overvalued right now?
10x Genomics (MEX:TXG) has a current Total Inventories of MXN965 Mil. The stock's GF Value™ is MXN200.14, compared to a current price of MXN335.54 — trading 67.7% above its estimated fair value. The current Total Inventories is MXN965 Mil. 10x Genomics' overall GF Score™ is 68/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For 10x Genomics (MEX:TXG), the current Total Inventories is MXN965 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 10x Genomics (MEX:TXG) Overvalued in 2026?
Based on GuruFocus' analysis, 10x Genomics stock appears to be overvalued.
The current stock price of MXN335.54 is trading 67.7% above its estimated GF Value™ of MXN200.14.
Key valuation signals for MEX:TXG:
Total Inventories: MXN965 Mil
GF Value™: MXN200.14 vs. price of MXN335.54 (67.7% above fair value)
No single metric tells the full story. See the MEX:TXG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
68GF Score
Get the complete analysis for MEX:TXG
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:TXG has been successfully added to your 
